Diabetes Mellitus Pregnancy Clinical Trial
Official title:
Glycemic Control and Iron Status in Diabetic Pregnancies - a Study of New Markers
This is an observational study at the Obstetrical outpatient clinic at Stavanger University
Hospital. The main goal is to compare the current marker of glycemic control (glycated
hemoglobin A1c, HbA1c) with glycated albumin in pregnancies with pregestational diabetes
mellitus.
Women with diabetes are at increased risk for adverse pregnancy outcomes. With improved
glycemic control, the risk decreases. Glycated albumin is suggested to be a better marker for
monitoring glycemic control in pregnancies because it reflects blood glucose for a shorter
period than HbA1c (3 versus 8-12 weeks). Other studies have shown that HbA1c increases in
pregnancy because of iron deficiency. The investigators want to investigate HbA1c, glycated
albumin and iron status in diabetic pregnancies. The investigators will compare HbA1c and
glycated albumin throughout pregnancy with the patient's own blood glucose measurements or
data from CGM (continuous blood glucose monitoring). Blood samples for HbA1c and glycated
albumin will be taken 6 times during pregnancy (week 12, 20, 24, 28, 32, 36).
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT05479214 -
Effect of Adding Metformin to Insulin in Uncontrolled Diabetic Patients During the 3rd Trimester of Pregnancy
|
Phase 4 |